Literature DB >> 483856

A multi-dose study on the human metabolism of amylobarbitone.

W C Baldeo, J N Gilbert, J W Powell.   

Abstract

1. The metabolism of amylobarbitone has been investigated in two healthy male volunteers, and the urinary excretion of unchanged drug, and the products of omega and omega-1 oxidation, quantitatively determined for four days after each of three doses to each volunteer. 2. In contrast to observations with butobarbitone, amylobarbitone was shown to have little effect on the rate of its own metabolism. 3. The t 1/2 for urinary excretion of the parent drug was 16.3 h while that for the two metabolites was 22.2 h.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 483856     DOI: 10.3109/00498257909038722

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  4 in total

1.  Stereochemical characterization of the diastereomers of the amobarbital N-glucosides excreted in human urine.

Authors:  W H Soine; P J Soine; F C Wireko; D J Abraham
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  An assessment of short-cut procedures for studying drug metabolism in vivo using amobarbital as a model drug.

Authors:  B K Tang; W Kalow; L Endrenyi; F Y Chan
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Multidose studies in the human metabolism of pentobarbitone.

Authors:  W C Baldeo; J N Gilbert; J W Powell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

4.  Time-dependent pharmacokinetics of high dose thiopental infusion in intensive care patients.

Authors:  H Russo; M P Dubboin; F Bressolle; S Urien
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.